What are Cannabinoid receptor agonist drugs?

Cannabinoid receptor agonist drugs are pharmacologic agents that share a common mechanism (typically targeting CB1 receptor, CB2 receptor). 0 are currently marketed, with 6 more in clinical development.

Cannabinoid receptor agonist

0 marketed 3 in Phase 3 3 in Phase 2

This page covers all Cannabinoid receptor agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting CB1 receptor, CB2 receptor, CB1/CB2 receptors, CB1 and CB2 receptors.

Targets

CB1 receptor, CB2 receptor · CB1/CB2 receptors · CB1 and CB2 receptors · CB1

Phase 3 pipeline (3)

Dronabinol in Oral Dosage Form · Arbeitsgemeinschaft medikamentoese Tumortherapie · Oncology
Dronabinol is a synthetic cannabinoid that acts as a partial agonist at cannabinoid receptors CB1 and CB2, modulating endocannabinoid signaling to produce therapeutic effects.
CimetrA-2 · MGC Pharmaceuticals d.o.o · Pain management
CimetrA-2 is a synthetic cannabinoid receptor agonist.
Dronabinol Capsules · Montefiore Medical Center · Oncology, Gastroenterology, Neurology
Dronabinol is a synthetic cannabinoid that acts as a partial agonist at cannabinoid CB1 and CB2 receptors in the central and peripheral nervous systems.

Phase 2 pipeline (3)

Cannabidiol 400 · Hurd,Yasmin, Ph.D. · Neurology
Cannabidiol 400 acts as a cannabinoid receptor agonist, modulating the endocannabinoid system to exert therapeutic effects.
4F-PCC · AstraZeneca · Pain management
4F-PCC is a synthetic cannabinoid receptor agonist.
Cannabinoids - whole plant extract · Shaare Zedek Medical Center · Neurology
Activates cannabinoid receptors